DK0964874T3 - CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf - Google Patents
CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse derafInfo
- Publication number
- DK0964874T3 DK0964874T3 DK98908948T DK98908948T DK0964874T3 DK 0964874 T3 DK0964874 T3 DK 0964874T3 DK 98908948 T DK98908948 T DK 98908948T DK 98908948 T DK98908948 T DK 98908948T DK 0964874 T3 DK0964874 T3 DK 0964874T3
- Authority
- DK
- Denmark
- Prior art keywords
- caml
- methods
- nucleic acids
- encoding nucleic
- surface receptor
- Prior art date
Links
- 102100025594 Guided entry of tail-anchored proteins factor CAMLG Human genes 0.000 title 1
- 101000932902 Homo sapiens Guided entry of tail-anchored proteins factor CAMLG Proteins 0.000 title 1
- 210000004698 lymphocyte Anatomy 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 abstract 3
- 101710178302 Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 1
- 108020001756 ligand binding domains Proteins 0.000 abstract 1
- 210000004898 n-terminal fragment Anatomy 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/810,572 US5969102A (en) | 1997-03-03 | 1997-03-03 | Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
PCT/US1998/004270 WO1998039361A1 (en) | 1997-03-03 | 1998-03-03 | A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0964874T3 true DK0964874T3 (da) | 2007-12-10 |
Family
ID=25204137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98908948T DK0964874T3 (da) | 1997-03-03 | 1998-03-03 | CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf |
Country Status (11)
Country | Link |
---|---|
US (7) | US5969102A (da) |
EP (3) | EP1632500B1 (da) |
JP (1) | JP3594975B2 (da) |
AT (1) | ATE373012T1 (da) |
AU (1) | AU732119B2 (da) |
CA (1) | CA2284078C (da) |
DE (1) | DE69838417T2 (da) |
DK (1) | DK0964874T3 (da) |
ES (2) | ES2552095T3 (da) |
PT (1) | PT964874E (da) |
WO (1) | WO1998039361A1 (da) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6830751B1 (en) * | 1994-03-14 | 2004-12-14 | Genetics Institute, Llc | Use of IL-12 antagonists in the treatment of rheumatoid arthritis |
ZA95960B (en) * | 1994-03-14 | 1995-10-10 | Genetics Inst | Use of interleukin-12 antagonists in the treatment of autoimmune diseases |
US8212004B2 (en) * | 1999-03-02 | 2012-07-03 | Human Genome Sciences, Inc. | Neutrokine-alpha fusion proteins |
US6812327B1 (en) * | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US5969102A (en) * | 1997-03-03 | 1999-10-19 | St. Jude Children's Research Hospital | Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
GB9828628D0 (en) | 1998-12-23 | 1999-02-17 | Glaxo Group Ltd | Novel ligand |
AU2005200008B2 (en) * | 1999-01-07 | 2008-03-06 | Zymogenetics, Inc. | Soluble receptor BR43x2 and methods of using |
ATE453712T1 (de) * | 1999-01-07 | 2010-01-15 | Zymogenetics Inc | Verfahren zur therapeutischen verwendung von löslichen rezeptoren br43x2 |
US20060067933A1 (en) * | 1999-01-07 | 2006-03-30 | Gross Jane A | Soluble receptor BR43x2 and methods of using |
US7833529B1 (en) | 1999-01-07 | 2010-11-16 | Zymogenetics, Inc. | Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor |
US20050100548A1 (en) * | 2001-07-24 | 2005-05-12 | Biogen Idec Ma Inc. | BAFF, inhibitors thereof and their use in the modulation of B-cell response |
KR100834809B1 (ko) * | 1999-01-25 | 2008-06-05 | 바이오겐 아이덱 엠에이 인코포레이티드 | Baff, 관련 차단제 및 면역 반응에서 b 세포와면역글로불린을 촉진 및 억제하는데에 있어서 이들의 용도 |
US20030095967A1 (en) * | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
AU3633000A (en) * | 1999-03-26 | 2000-10-16 | Human Genome Sciences, Inc. | Neutrokine-alpha binding proteins and methods based thereon |
US20030022233A1 (en) * | 1999-04-30 | 2003-01-30 | Raymond G. Goodwin | Methods of use of the taci/taci-l interaction |
PL207501B1 (pl) * | 1999-08-17 | 2010-12-31 | Apotech R & D Sa | Zastosowanie polipeptydu BCMA oraz przeciwciała skierowanego przeciwko BCMA |
UA74798C2 (uk) * | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами |
EP1254227A2 (en) * | 2000-02-11 | 2002-11-06 | Amgen Inc. | Fusion receptor from tnf family |
IL150755A0 (en) * | 2000-02-16 | 2003-02-12 | Genentech Inc | Uses of agonists and antagonists to modulate activity of tnf-related molecules |
US6969519B2 (en) * | 2000-03-10 | 2005-11-29 | Human Genome Sciences, Inc. | Methods of using an agonistic antibody human tumor necrosis factor receptor (TR17) |
KR20020093029A (ko) | 2000-04-11 | 2002-12-12 | 제넨테크, 인크. | 다가 항체 및 그의 용도 |
EP1746106A3 (en) * | 2000-04-27 | 2007-03-14 | Biogen Idec MA Inc. | Use of TACI as an anti-tumor agent |
CA2404945C (en) * | 2000-04-27 | 2010-02-09 | Biogen, Inc. | Taci as an anti-tumor agent |
US20040013674A1 (en) * | 2001-04-27 | 2004-01-22 | Christine Ambrose | Taci as an anti-tumor agent |
AU2001261557B2 (en) * | 2000-05-12 | 2005-06-30 | Amgen Inc. | Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
WO2001096528A2 (en) * | 2000-06-15 | 2001-12-20 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
US7879328B2 (en) | 2000-06-16 | 2011-02-01 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator |
WO2002002641A1 (en) * | 2000-06-16 | 2002-01-10 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to blys |
CN1249227C (zh) * | 2000-07-07 | 2006-04-05 | 卫材株式会社 | 真菌细胞壁合成基因 |
ATE415978T1 (de) | 2000-07-27 | 2008-12-15 | Genentech Inc | Sequentielle verabreichung von cpt-11 und apo-2l polypeptid |
US20030091565A1 (en) * | 2000-08-18 | 2003-05-15 | Beltzer James P. | Binding polypeptides and methods based thereon |
UA83458C2 (uk) * | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf) |
WO2002046231A2 (en) * | 2000-12-07 | 2002-06-13 | The University Of British Columbia | Caml-binding peptides |
EP2301971A1 (en) * | 2001-02-20 | 2011-03-30 | ZymoGenetics, L.L.C. | Antibodies that bind both BCMA and TACI |
DK1385882T3 (da) * | 2001-05-11 | 2008-02-11 | Amgen Inc | Peptider og relaterede molekyler, der binder til TALL-1 |
KR101021124B1 (ko) | 2001-05-24 | 2011-03-14 | 지모제넥틱스, 인코포레이티드 | Taci-면역글로불린 융합 단백질 |
MXPA04000134A (es) | 2001-06-26 | 2005-06-06 | Abgenix Inc | Anticuerpos para ligandos de osteoprotegerina. |
DE10131922A1 (de) * | 2001-07-02 | 2003-01-30 | Brahms Ag | Verwendung des Calcineurin B Homologen Proteins (CHP) für die Diagnose und Therapie von Entzündungserkrankungen und Sepsis |
ATE433996T1 (de) | 2001-07-03 | 2009-07-15 | Genentech Inc | Humane dr4-antikörper und deren anwendungen |
EP1414948B1 (en) * | 2001-07-10 | 2009-09-16 | Biogen Idec Inc. | Inhibition of apoptosis process and improvement of cell performance |
HUP0500992A3 (en) * | 2001-08-03 | 2007-11-28 | Genentech Inc | Tacis and br3 polypeptides and uses thereof |
US6551615B1 (en) * | 2001-10-18 | 2003-04-22 | M/S. Strides Arcolab Limited | Dexibuprofen-containing soft gelatin capsules and process for preparing the same |
AU2003221256A1 (en) * | 2002-02-21 | 2003-09-09 | Biogen Idec Ma Inc. | Use of bcma as an immunoregulatory agent |
US20040038303A1 (en) * | 2002-04-08 | 2004-02-26 | Unger Gretchen M. | Biologic modulations with nanoparticles |
US8025873B2 (en) * | 2002-06-20 | 2011-09-27 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US6890725B2 (en) * | 2002-07-23 | 2005-05-10 | Rigel Pharmaceuticals, Inc. | Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use |
AU2003256836A1 (en) * | 2002-07-25 | 2004-02-16 | Genentech, Inc. | Taci antibodies and uses thereof |
EP1558278B1 (en) * | 2002-10-11 | 2009-09-02 | ZymoGenetics, Inc. | Production of homotrimeric fusion proteins |
CA2520097C (en) | 2003-03-28 | 2014-10-07 | Biogen Idec Ma Inc. | Truncated baff receptors |
ES2538469T3 (es) | 2003-06-05 | 2015-06-22 | Genentech, Inc. | Terapia de combinación para trastornos de células B |
US20050163775A1 (en) * | 2003-06-05 | 2005-07-28 | Genentech, Inc. | Combination therapy for B cell disorders |
US7211407B2 (en) * | 2003-07-15 | 2007-05-01 | Chan Test, Inc. | High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
CA2554526A1 (en) * | 2004-01-29 | 2005-08-18 | Genentech, Inc. | Variants of the extracellular domain of bcma and uses thereof |
WO2005087810A2 (en) | 2004-03-08 | 2005-09-22 | Zymogenetics, Inc. | Dimeric fusion proteins and materials and methods for producing them |
US20080181886A1 (en) * | 2004-11-04 | 2008-07-31 | Genentech, Inc. | Polypeptides That Bind Baff And/Or April |
EP1855711B1 (en) * | 2005-01-28 | 2009-06-17 | Biogen Idec MA Inc. | USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS |
ZA200801354B (en) * | 2005-08-09 | 2009-08-26 | Ares Trading Sa | Methods for treating B-cell malignancies using TACI-lg fusion molecule |
JP5118037B2 (ja) * | 2005-08-09 | 2013-01-16 | ザイモジェネティクス, インコーポレイテッド | Taci融合分子を用いた異常細胞増殖の処置及び予防のための方法 |
US9168286B2 (en) * | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
EA015860B1 (ru) * | 2005-10-13 | 2011-12-30 | Хьюман Дженом Сайенсиз, Инк. | Способы лечения аутоиммунных заболеваний при использовании антагониста нейтрокина-альфа |
AR056806A1 (es) | 2005-11-14 | 2007-10-24 | Amgen Inc | Moleculas quimericas de anticuerpo rankl- pth/ pthrp |
AU2006318539B2 (en) * | 2005-11-23 | 2012-09-13 | Genentech, Inc. | Methods and compositions related to B cell assays |
WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
BRPI0711823A2 (pt) * | 2006-05-15 | 2012-01-17 | Ares Trading Sa | métodos para tratamento de doenças auto-imunes com uma molécula de fusão taci-ig |
CN101541825B (zh) * | 2006-08-28 | 2013-08-14 | 阿雷斯贸易股份有限公司 | Fc融合蛋白的纯化方法 |
US8513393B2 (en) | 2006-08-28 | 2013-08-20 | Ares Trading S.A. | Process for the purification of Fc-containing proteins |
ATE509107T1 (de) | 2007-01-26 | 2011-05-15 | Merck Serono Sa | Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik |
EP2200631A1 (en) | 2007-10-16 | 2010-06-30 | Zymogenetics, Inc. | Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
EP2396035A4 (en) * | 2009-02-12 | 2012-09-12 | Human Genome Sciences Inc | USE OF ANTAGONISTS OF PROTEIN STIMULATING LYMPHOCYTES B TO PROMOTE GRAFT TOLERANCE |
WO2011109280A1 (en) | 2010-03-05 | 2011-09-09 | Lerner Research Institute | Methods and compositions to treat immune-mediated disorders |
JOP20140087B1 (ar) | 2013-03-13 | 2021-08-17 | Amgen Inc | بروتينات مخصصة ل baff و b7rp1 وإستخداماتها |
US9458246B2 (en) | 2013-03-13 | 2016-10-04 | Amgen Inc. | Proteins specific for BAFF and B7RP1 |
AU2018219226A1 (en) | 2017-02-07 | 2019-08-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents |
WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
CN112055595A (zh) | 2018-01-22 | 2020-12-08 | 恩多塞特公司 | Car t细胞的使用方法 |
PE20230494A1 (es) | 2020-05-08 | 2023-03-23 | Alpine Immune Sciences Inc | Proteinas inmunomoduladoras inhibidoras de april y baff y metodos de uso de las mismas |
KR20220086522A (ko) * | 2020-12-16 | 2022-06-23 | 주식회사 굳티셀 | Taci 단백질의 용도 |
JP2024510636A (ja) | 2021-08-10 | 2024-03-08 | レメゲン シーオー.,エルティーディー. | TACI-Fc融合タンパク質を用いたIgA腎症の治療方法 |
WO2023051660A1 (zh) | 2021-09-30 | 2023-04-06 | 荣昌生物制药(烟台)股份有限公司 | 用TACI-Fc融合蛋白治疗干燥综合征的方法 |
CA3236667A1 (en) | 2022-06-08 | 2023-12-14 | Jianmin Fang | Method for treating myasthenia gravis with taci-fc fusion protein |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
NL7807532A (nl) | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
NL8000173A (nl) | 1980-01-11 | 1981-08-03 | Akzo Nv | Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen. |
US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
US4703017C1 (en) | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
US4751181A (en) * | 1984-12-31 | 1988-06-14 | Duke University | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
CA1338860C (en) | 1987-04-13 | 1997-01-21 | Peter Parker | Radiolabelling of proteins |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
EP0280559B1 (en) | 1987-02-27 | 1993-10-20 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Agglutination immunoassay and kit for determination of a multivalent immune species using a buffered salt wash solution |
DE3882058T2 (de) | 1987-02-27 | 1994-01-13 | Eastman Kodak Co | Immunoreaktives Reagens, Verfahren zu seiner Herstellung und seine Verwendung zur Bestimmung einer immunoreaktiven Spezies. |
US4857453A (en) | 1987-04-07 | 1989-08-15 | Syntex (U.S.A.) Inc. | Immunoassay device |
ATE195022T1 (de) | 1987-04-27 | 2000-08-15 | Unilever Nv | Spezifische bindungstestverfahren |
US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
DE3856559T2 (de) | 1987-05-21 | 2004-04-29 | Micromet Ag | Multifunktionelle Proteine mit vorbestimmter Zielsetzung |
US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
IL92124A (en) | 1988-10-28 | 1996-10-31 | Sidney Pestka | Recombinant proteins modified to contain post-phosphorylation that do not occur in nature |
US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
US5354844A (en) | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5139749A (en) | 1990-06-22 | 1992-08-18 | Tas, Inc. | Fluidized calcining process |
CA2074825C (en) | 1990-12-14 | 2005-04-12 | Daniel J. Capon | Chimeric chains for receptor-associated signal transduction pathways |
WO1992013878A2 (en) | 1991-02-07 | 1992-08-20 | Board Of Trustees Of The University Of Illinois | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
NZ267843A (en) | 1993-05-27 | 1997-10-24 | Selectide Corp | Libraries of synthetic test compound attached to separate phase synthesis supports |
JPH09501055A (ja) | 1993-07-30 | 1997-02-04 | ユニバーシティ オブ メディシン アンド デンティストリー オブ ニュージャージー | 初代リンパ球への効率的遺伝子転移 |
US5650550A (en) * | 1993-10-01 | 1997-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Mutant mice having a deficit of functional estrogen receptors |
WO1995028494A1 (en) | 1994-04-15 | 1995-10-26 | Targeted Genetics Corporation | Gene delivery fusion proteins |
US5523227A (en) * | 1994-06-17 | 1996-06-04 | The Board Of Trustees Of The Leland Stanford Junior Univ. | DNA encoding calcium-signal modulating cyclophilin ligand |
JP3787355B2 (ja) * | 1994-12-15 | 2006-06-21 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | Fas/apo1受容体機能のモジュレーター |
US5741899A (en) | 1995-02-02 | 1998-04-21 | Cell Genesys, Inc. | Chimeric receptors comprising janus kinase for regulating cellular pro liferation |
US5712149A (en) | 1995-02-03 | 1998-01-27 | Cell Genesys, Inc. | Chimeric receptor molecules for delivery of co-stimulatory signals |
US6103521A (en) | 1995-02-06 | 2000-08-15 | Cell Genesys, Inc. | Multispecific chimeric receptors |
US5969102A (en) | 1997-03-03 | 1999-10-19 | St. Jude Children's Research Hospital | Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
US6685728B2 (en) * | 2002-01-25 | 2004-02-03 | Stryker Endoscopy | Threaded suture anchor and method of use |
US9002545B2 (en) | 2011-01-07 | 2015-04-07 | Wabtec Holding Corp. | Data improvement system and method |
-
1997
- 1997-03-03 US US08/810,572 patent/US5969102A/en not_active Expired - Lifetime
-
1998
- 1998-03-03 CA CA2284078A patent/CA2284078C/en not_active Expired - Lifetime
- 1998-03-03 ES ES05020384.3T patent/ES2552095T3/es not_active Expired - Lifetime
- 1998-03-03 EP EP05020384.3A patent/EP1632500B1/en not_active Expired - Lifetime
- 1998-03-03 AT AT98908948T patent/ATE373012T1/de active
- 1998-03-03 EP EP10179571A patent/EP2292654A3/en not_active Withdrawn
- 1998-03-03 DE DE69838417T patent/DE69838417T2/de not_active Expired - Lifetime
- 1998-03-03 EP EP98908948A patent/EP0964874B1/en not_active Expired - Lifetime
- 1998-03-03 ES ES98908948T patent/ES2292201T3/es not_active Expired - Lifetime
- 1998-03-03 PT PT98908948T patent/PT964874E/pt unknown
- 1998-03-03 AU AU66854/98A patent/AU732119B2/en not_active Expired
- 1998-03-03 DK DK98908948T patent/DK0964874T3/da active
- 1998-03-03 JP JP53877898A patent/JP3594975B2/ja not_active Expired - Lifetime
- 1998-03-03 WO PCT/US1998/004270 patent/WO1998039361A1/en active IP Right Grant
-
1999
- 1999-04-12 US US09/290,333 patent/US6316222B1/en not_active Expired - Lifetime
-
2001
- 2001-02-14 US US09/782,857 patent/US6500428B1/en not_active Expired - Lifetime
-
2002
- 2002-11-12 US US10/293,816 patent/US20030082173A1/en not_active Abandoned
-
2005
- 2005-03-14 US US11/079,418 patent/US20050183148A1/en not_active Abandoned
- 2005-12-23 US US11/318,156 patent/US7355005B2/en not_active Expired - Fee Related
-
2008
- 2008-02-07 US US12/027,720 patent/US20090226473A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998039361A1 (en) | 1998-09-11 |
EP1632500A2 (en) | 2006-03-08 |
EP2292654A3 (en) | 2012-07-25 |
US6316222B1 (en) | 2001-11-13 |
ATE373012T1 (de) | 2007-09-15 |
US5969102A (en) | 1999-10-19 |
US7355005B2 (en) | 2008-04-08 |
US6500428B1 (en) | 2002-12-31 |
EP1632500B1 (en) | 2015-08-05 |
AU6685498A (en) | 1998-09-22 |
US20030082173A1 (en) | 2003-05-01 |
JP2001518080A (ja) | 2001-10-09 |
EP2292654A2 (en) | 2011-03-09 |
ES2552095T3 (es) | 2015-11-25 |
DE69838417D1 (de) | 2007-10-25 |
CA2284078C (en) | 2014-09-09 |
DE69838417T2 (de) | 2008-05-29 |
EP0964874A1 (en) | 1999-12-22 |
AU732119B2 (en) | 2001-04-12 |
CA2284078A1 (en) | 1998-09-11 |
US20050183148A1 (en) | 2005-08-18 |
EP0964874B1 (en) | 2007-09-12 |
ES2292201T3 (es) | 2008-03-01 |
JP3594975B2 (ja) | 2004-12-02 |
PT964874E (pt) | 2007-12-21 |
US20060101529A1 (en) | 2006-05-11 |
US20090226473A1 (en) | 2009-09-10 |
EP1632500A3 (en) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0964874T3 (da) | CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf | |
NO20010320D0 (no) | Nukleinsyrer som koder for en G-proteinkoblet reseptor som er involvert i sensorisk transduksjon | |
ATE358178T1 (de) | Modulierung der tnf-rezeptoraktivität | |
NO961115L (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
DK1482042T3 (da) | Aktive og inaktive CC-kemokinreceptorer og nukleinsyremolekyler der koder for receptoren | |
DE69431805D1 (de) | Struktur höherer ordnung und bindung von peptidnukleinsäuren | |
PL336306A1 (en) | Proteinous fusions of tgf-beta ii type receptor with a constant immunoglobulin area | |
BR9912545A (pt) | ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial | |
AU1846995A (en) | Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay | |
DE60335216D1 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
NO970740L (no) | Glutamat reseptor | |
DK1011704T3 (da) | Tumornekrose-faktor-receptor-afledte peptid-analiger | |
DE69709561D1 (de) | Östrogen-Rezeptor | |
DK0840615T3 (da) | Kemokin-bindende protein og fremgangsmåder til anvendelse deraf | |
FI970783A (fi) | Trefoil-peptididimeeri | |
AR010041A1 (es) | Agonistas multifuncionales quimericos de receptores de hematopoyetina | |
NO973422D0 (no) | Recombinant C140-reseptor, dens agonister og antagonister og nukleinsyrer som koder for reseptoren | |
DK0968288T3 (da) | z219a, en human homolog til 2-19 protein | |
ATE462721T1 (de) | Breit einsetzbares verfahren zur identifizierung von modulatoren von g-protein gekoppelten rezeptoren | |
WO2000011204A3 (en) | Homer interacting proteins | |
SE9701010D0 (sv) | Antibody | |
DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
NO984233L (no) | Cytokin kalt lerk-8 | |
DK130290A (da) | Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner | |
AU3169599A (en) | Method for screening substance promoting oligomerization of receptor protein molecules |